Ceftazidime and Drug toxicity - a phase IV clinical study of FDA data

Summary:

Drug toxicity is reported as a side effect among people who take Ceftazidime (ceftazidime), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Vancomycin, and have Hiv infection.

The phase IV clinical study analyzes which people have Drug toxicity when taking Ceftazidime. It is created by eHealthMe based on reports of 10,307 people who have side effects when taking Ceftazidime from the FDA, and is updated regularly.

What is Ceftazidime?

Ceftazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,327 Ceftazidime users. Check the latest studies of Ceftazidime.

What is Drug toxicity?

Drug toxicity is found to be associated with 981 drugs and 1,385 conditions by eHealthMe. Check the latest studies of Drug toxicity.

On Aug, 03, 2026

10,307 people reported to have side effects when taking Ceftazidime.
Among them, 45 people (0.44%) have Drug toxicity.

Among these 45 people:

How long have people been on Ceftazidime when they have Drug toxicity? *

What is the gender of people who have Drug toxicity when taking Ceftazidime? *

female: 38.64 %
male: 61.36 %

What is the age of people who have Drug toxicity when taking Ceftazidime? *

What are other drugs people take besides Ceftazidime? *

What are other side effects people have besides Drug toxicity? *

Fever: 14 people, 31.11%
Acute Kidney Failure: 10 people, 22.22%
Multi-Organ Failure (multisystem organ failure): 10 people, 22.22%
Cardiac Arrest: 9 people, 20.00%
Hypotension (abnormally low blood pressure): 9 people, 20.00%
Blood Creatinine Increased: 8 people, 17.78%
Pleural Effusion (water on the lungs): 6 people, 13.33%
Hepatic Failure (liver failure): 5 people, 11.11%
Cardiac Tamponade (fluid accumulates in heart covering): 5 people, 11.11%
Mental Status Changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation): 5 people, 11.11%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 4.44%
Cardiomyopathy (weakening of the heart muscle): 2 people, 4.44%
Pneumonia: 2 people, 4.44%
Fever: 2 people, 4.44%
Hiv Infection: 2 people, 4.44%
Infection: 1 person, 2.22%
B Precursor Type Acute Leukaemia (lymphoid cancer): 1 person, 2.22%
Burkitt's Lymphoma Stage Iii (blood cancer stage iii): 1 person, 2.22%
Cellulitis (infection under the skin): 1 person, 2.22%
Chemotherapeutic Drug Level Above Therapeutic: 1 person, 2.22%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftazidime and have Drug toxicity?

- Check whether Drug toxicity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ceftazidime:

Ceftazidime (10,327 reports)

Drug toxicity treatments and more:

Drug toxicity (20,259 reports)

Browse all side effects of Ceftazidime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drug toxicity:

Drug toxicity (981 drugs)

Browse all the conditions that are associated with Drug toxicity:

Drug toxicity (1,385 conditions)

Related publications that referenced our studies

Chen F, Zhan Z, "Severe drug-induced immune haemolytic anaemia due to ceftazidime", Blood Transfusion, 2014 Jan .
Wandalkar P, Daswani BR, Pandit PT, Ghongane BB, "A case of Phenytoin toxicity", INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY, 2014 Jan .
Chen F, Zhan Z, "Severe drug-induced immune haemolytic anaemia due to ceftazidime", Blood Transfusion, 2014 Jan .
Wandalkar P, Daswani BR, Pandit PT, Ghongane BB, "A case of Phenytoin toxicity", INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on ceftazidime (the active ingredients of Ceftazidime) and Ceftazidime (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.